Altamira Therapeutics Ltd.: xbrl:ActuarialAssumptionOfDiscountRates
| Value | {"value": 0.0097} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/20b7823a-575d-4b45-8a53-c52f42246118
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-037199Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/20b7823a-575d-4b45-8a53-c52f42246118
History
- no predecessors — first report